A fully automated, continuous-flow radioimmunoassay for methotrexate

Area of Science:

• Clinical Chemistry
• Analytical Chemistry
• Biomedical Engineering

Background:

• Accurate methotrexate monitoring is crucial for optimizing therapeutic efficacy and minimizing toxicity.
• Existing manual radioimmunoassays can be time-consuming and labor-intensive.
• The need for rapid, high-throughput analytical methods in clinical settings is increasing.

Purpose of the Study:

• To develop and validate a fully automated continuous-flow radioimmunoassay for methotrexate.
• To assess the assay's performance characteristics, including precision, speed, sensitivity, and accuracy.

Main Methods:

• Utilized [125I]Histamine-labeled methotrexate as a tracer.
• Employed anti-methotrexate serum coupled to a magnetizable solid-phase for separation via an electromagnetic field.
• Implemented a continuous-flow system for automated sample processing.

Main Results:

• Achieved high precision (CV < 2.5%) and throughput (30 samples/hour).
• Demonstrated a short incubation time (10 min) and rapid assay completion (15 min/sample).
• Exhibited excellent sensitivity (1–100 µg/L) and no significant carryover between samples.
• Showed strong correlation with manual radioimmunoassay (r=0.99) and competitive protein-binding assay (r=0.96).

Conclusions:

• The automated continuous-flow radioimmunoassay is a precise, rapid, and sensitive method for methotrexate determination.
• This automated assay offers significant advantages over manual methods for clinical laboratory applications.
• The system's efficiency and accuracy support its potential for routine methotrexate monitoring.